Investor’s Delight: Bicara Therapeutics Inc (BCAX) Closes Strong at 9.29, Up 6.66

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

The closing price of Bicara Therapeutics Inc (NASDAQ: BCAX) was $9.29 for the day, up 6.66% from the previous closing price of $8.71. In other words, the price has increased by $6.66 from its previous closing price. On the day, 1.07 million shares were traded. BCAX stock price reached its highest trading level at $9.42 during the session, while it also had its lowest trading level at $8.575.

Ratios:

Our analysis of BCAX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 24.62 and its Current Ratio is at 24.62. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On April 17, 2025, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $8.

On February 06, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $31.Wedbush initiated its Outperform rating on February 06, 2025, with a $31 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 16 ’25 when Meisner Lara sold 15,829 shares for $10.43 per share. The transaction valued at 165,096 led to the insider holds 0 shares of the business.

LARA S. MEISNER bought 31,658 shares of BCAX for $343,173 on Jun 16 ’25. On Mar 14 ’25, another insider, Meisner Lara, who serves as the Chief Legal Officer of the company, sold 79,146 shares for $12.90 each. As a result, the insider received 1,021,211 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAX now has a Market Capitalization of 506641280 and an Enterprise Value of 45167464.

Stock Price History:

Over the past 52 weeks, BCAX has reached a high of $28.09, while it has fallen to a 52-week low of $7.80. The 50-Day Moving Average of the stock is -23.33%, while the 200-Day Moving Average is calculated to be -42.04%.

Shares Statistics:

BCAX traded an average of 876.44K shares per day over the past three months and 932350 shares per day over the past ten days. A total of 54.53M shares are outstanding, with a floating share count of 32.77M. Insiders hold about 39.92% of the company’s shares, while institutions hold 62.30% stake in the company. Shares short for BCAX as of 1749772800 were 5084728 with a Short Ratio of 5.80, compared to 1747267200 on 7417157. Therefore, it implies a Short% of Shares Outstanding of 5084728 and a Short% of Float of 14.59.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.